Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Methyl-5-deoxy-2,3-O-isopropylidene-D-ribofuranoside, also known as 5-Deoxy-2,3-O-(1-methylethylidene)-D-ribofuranoside Methyl Ether, is a chemical compound that serves as an intermediate in the synthesis of Capecitabine-related compounds. It is a modified form of D-ribofuranoside, with a methyl group and an isopropylidene protecting group attached to the 2,3-O position, and the 5-O position is deoxylated.

78341-97-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • High quality Methyl-5-Deoxy-2,3-O-Isopropylidene-D-Ribofuranoside(Capacitabine Intermediate) supplier in China

    Cas No: 78341-97-6

  • No Data

  • 1 Metric Ton

  • 30 Metric Ton/Month

  • Simagchem Corporation
  • Contact Supplier
  • 78341-97-6 Structure
  • Basic information

    1. Product Name: Methyl-5-deoxy-2,3-O-isopropylidene-D-ribofuranoside
    2. Synonyms: METHYL-5-DEOXY-2,3-O-ISOPROPYLIDENE-D-RIBOFURANOSIDE;thyl-5-deoxy-2,3-O-isopropylidene-D-ribofuranoside
    3. CAS NO:78341-97-6
    4. Molecular Formula: C9H16O4
    5. Molecular Weight: 188.22
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 78341-97-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 73-75 °C(Press: 12 Torr)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.11±0.1 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Methyl-5-deoxy-2,3-O-isopropylidene-D-ribofuranoside(CAS DataBase Reference)
    10. NIST Chemistry Reference: Methyl-5-deoxy-2,3-O-isopropylidene-D-ribofuranoside(78341-97-6)
    11. EPA Substance Registry System: Methyl-5-deoxy-2,3-O-isopropylidene-D-ribofuranoside(78341-97-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 78341-97-6(Hazardous Substances Data)

78341-97-6 Usage

Uses

Used in Pharmaceutical Industry:
Methyl-5-deoxy-2,3-O-isopropylidene-D-ribofuranoside is used as a key intermediate in the synthesis of Capecitabine (C175650) and its related compounds. Capecitabine is an orally administered anticancer drug that is converted into 5-fluorouracil (5-FU) in the body, which inhibits DNA synthesis and has been used to treat various types of cancer, including colorectal, breast, and ovarian cancers.
In the synthesis process, Methyl-5-deoxy-2,3-O-isopropylidene-D-ribofuranoside plays a crucial role in the formation of the final drug product, contributing to the development of new and effective cancer treatments. Its unique structure allows for specific chemical reactions that are essential for the production of Capecitabine and its analogs, making it a valuable component in the pharmaceutical industry.

Check Digit Verification of cas no

The CAS Registry Mumber 78341-97-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,3,4 and 1 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 78341-97:
(7*7)+(6*8)+(5*3)+(4*4)+(3*1)+(2*9)+(1*7)=156
156 % 10 = 6
So 78341-97-6 is a valid CAS Registry Number.

78341-97-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl-5-deoxy-2,3-O-isopropylidene-D-ribofuranoside

1.2 Other means of identification

Product number -
Other names Methyl-(5-desoxy-2,3-O-isopropyliden-D-ribofuranosid)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:78341-97-6 SDS

78341-97-6Relevant articles and documents

Industrial large-scale production method of capecitabine intermediate

-

Paragraph 0045; 0046, (2020/09/20)

The invention provides an industrial large-scale production method of a capecitabine intermediate. The industrial large-scale production method adopts a one-pot production method of simultaneously adding methanol and acetone, and is a preparation method which is energy-saving, short in production period and high in yield; a method of adding low-boiling-point solvents such as ethyl acetate into dimethyl sulfoxide or pyrrolidone for reflux cooling to take away heat is adopted; and a production method of hydrolyzing while distilling is designed, the methanol and the acetone which are generated byhydrolysis are distilled out, the methanol and the acetone in water are continuously reduced, the reaction is carried out towards K3, and the reaction is complete and thorough.

Preparation method of capecitabine intermediate

-

Paragraph 0007; 0016-0017, (2019/12/02)

The invention discloses a preparation method of a capecitabine intermediate 1, 2, 3-O-triacetyl-5-deoxy-D-furanoside, which belongs to the technical field of medicinal chemistry. According to the invention, D-ribose (a compound I) is used as an initial raw material, and is subjected to a protective group reaction with methanol and acetone under the catalysis of solid acid, 1, 2, 3-hydroxyl is protected to obtain a compound II, then the compound II and thionyl chloride are subjected to a chlorination reaction, hydroxymethyl is changed into chloromethyl, a compound III is obtained, the compoundIII is subjected to a reduction reaction through platinum/carbon catalytic hydrogenation to obtain a compound IV, the compound IV is subjected to acidic hydrolysis to obtain a compound V, and the compound V is subjected to acetylation to obtain a target compound VI. The whole process is short in reaction step and high in economy; side reactions are few, and product purity is high; no wastewater isgenerated in the first three steps, so that the method is more environment-friendly; and the method is beneficial to industrial production of the capecitabine intermediate 1, 2, 3-O-triacetyl-5-deoxy-D-furanoside.

Capecitabine and wherein the intermediate preparation method

-

, (2017/02/09)

The invention discloses a preparation method of capecitabine. The method comprises the following steps: based on D-ribose serving as a starting raw material, carrying out hydroxyl protection, 5-site tosylation, iodine substitution, hypophosphorous acid deiodination and acetylation so as to obtain the key intermediate 12,3-tri-O-acetyl-5-deoxy-beta-D-ribofuranose; carrying out glycosylation on the key intermediate and 5-fluorocytosine; and finally, carrying out N-4 site acylation and deprotection so as to obtain the capecitabine. In the method, a metal catalyst dose not need to be used for participating in reaction, the reaction condition is mild, and the yield is high, thus the method is economical and effective as well as suitable for industrial production on a large scale.

PREPARATION OF CAPECITABINE

-

Page/Page column 22, (2010/06/20)

The present invention relates to substantially pure capecitabine and processes for the preparation thereof.

HYDROXAMIC ACID DERIVATIVES

-

, (2010/08/08)

The disclosure includes hydroxamic compounds of Formula I: (I) wherein P, Z, and m are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.

Benzimidazole 2'-isonucleosides: Design, synthesis, and antiviral activity of 2-substituted-5,6-dichlorobenzimidazole 2'-isonucleosides

Freeman,Selleseth,Rideout,Harvey

, p. 155 - 174 (2007/10/03)

2,5,6-Trihalogenated benzimidazole-β-D-ribofuranosyl nucleosides and 2- substituted amino-5,6-dichlorobenzimidazole-β-L-ribofuranosyl nucleosides are potent and selective inhibitors of human cytomegalovirus (HCMV). The D- ribofuranosyl analogs are metabolized rapidly in vivo rendering them unsuitable as drug candidates. The primary source of instability is thought to be the anomeric bond. The synthesis of a series of chemically stable benzimidazole-2'-isonucleosides is presented. The synthetic schemes employed are based on nucleophilic displacements of a 2'-tosylate from carbohydrate intermediates with 2-bromo-5,6-dichlorobenzidazole. 2-Bromo and 2-isopropyl amino analogs with 3'- and 5'-oxo and deoxy substitutions were prepared. The benzimidazole-2'-isonucleosides presented here demonstrated reduced activity against HCMV when compared to other D-ribofuranosyl benzimidazole analogs. In addition, they were not found to be inhibitors of HIV.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 78341-97-6